Literature DB >> 19101228

Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis.

Sijie Zheng1, Lisa de Las Fuentes, Andrew Bierhals, Rachel Ash-Bernal, Karen Spence, Eduardo Slatopolsky, Victor G Davila-Roman, James Delmez.   

Abstract

Vascular calcium deposition in end-stage renal disease occurs commonly, but its relation to cardiovascular risk factors and fetuin-A levels in African Americans is not known. Compliant African American patients who were undergoing hemodialysis (HD; n = 17) agreed to undergo 64-slice multidetector computed tomography for the assessment of coronary artery calcium score (CACS). The relation between traditional cardiovascular risk factors (i.e., age; gender; dialysis vintage; history of diabetes; means of the previous 3 years of weekly predialysis blood pressure values and hemoglobin levels; means of monthly values of calcium, phosphorus, alkaline phosphatase, uric acid; and albumin; and means of quarterly measurements of parathyroid hormone and lipids) and fetuin-A levels and CACS was explored using univariate analyses. Serum phosphorus levels over the previous 3 years were well controlled. The CACS range was 0 to 3,877 Agatston units (mean 996, median 196). Among the tested variables, only fetuin-A was significantly and inversely associated with CACS (standardized beta = -0.64, 95% confidence interval -18.09 to -3.62, p = 0.006). There was no association between age and fetuin-A level (standardized beta = -0.02, 95% confidence interval -0.10 to 0.23). In conclusion, African-American patients who were undergoing long-term hemodialysis and with good phosphorus control exhibited a strong inverse correlation between fetuin-A level and CACS that was independent of age.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101228      PMCID: PMC2631229          DOI: 10.1016/j.amjcard.2008.08.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  26 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling.

Authors:  Melanie Szweras; Danmei Liu; Emily A Partridge; Judy Pawling; Balram Sukhu; Cameron Clokie; Willi Jahnen-Dechent; Howard C Tenenbaum; Carol J Swallow; Marc D Grynpas; James W Dennis
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

3.  The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex.

Authors:  Paul A Price; Joo Eun Lim
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

4.  Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study.

Authors:  Markus Ketteler; Philipp Bongartz; Ralf Westenfeld; Joachim Ernst Wildberger; Andreas Horst Mahnken; Roland Böhm; Thomas Metzger; Christoph Wanner; Willi Jahnen-Dechent; Jürgen Floege
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

5.  Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

Authors:  Gérard M London; Alain P Guérin; Sylvain J Marchais; Fabien Métivier; Bruno Pannier; Hasan Adda
Journal:  Nephrol Dial Transplant       Date:  2003-09       Impact factor: 5.992

6.  Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat.

Authors:  Paul A Price; Matthew K Williamson; Thao Minh Thi Nguyen; Truclinh N Than
Journal:  J Biol Chem       Date:  2003-10-24       Impact factor: 5.157

7.  The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification.

Authors:  Cora Schafer; Alexander Heiss; Anke Schwarz; Ralf Westenfeld; Markus Ketteler; Jurgen Floege; Werner Muller-Esterl; Thorsten Schinke; Willi Jahnen-Dechent
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

8.  Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure.

Authors:  Jun Oh; Rainer Wunsch; Martin Turzer; Malte Bahner; Paolo Raggi; Uwe Querfeld; Otto Mehls; Franz Schaefer
Journal:  Circulation       Date:  2002-07-02       Impact factor: 29.690

9.  Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles.

Authors:  Alexander Heiss; Alexander DuChesne; Bernd Denecke; Joachim Grötzinger; Kazuhiko Yamamoto; Thomas Renné; Willi Jahnen-Dechent
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

10.  The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis.

Authors:  Kosaku Nitta; Takashi Akiba; Keiko Uchida; Akira Kawashima; Wako Yumura; Takashi Kabaya; Hiroshi Nihei
Journal:  Am J Kidney Dis       Date:  2003-08       Impact factor: 8.860

View more
  10 in total

Review 1.  The role of fetuin-A in mineral trafficking and deposition.

Authors:  Michael M X Cai; Edward R Smith; Stephen G Holt
Journal:  Bonekey Rep       Date:  2015-05-06

2.  Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients.

Authors:  O Ulutas; M C Taskapan; A Dogan; T Baysal; H Taskapan
Journal:  Int Urol Nephrol       Date:  2017-11-13       Impact factor: 2.370

3.  The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study.

Authors:  Joachim H Ix; Elizabeth Barrett-Connor; Christina L Wassel; Kevin Cummins; Jaclyn Bergstrom; Lori B Daniels; Gail A Laughlin
Journal:  J Am Coll Cardiol       Date:  2011-11-29       Impact factor: 24.094

4.  Effects of sodium thiosulfate on vascular calcification in end-stage renal disease: a pilot study of feasibility, safety and efficacy.

Authors:  Santhosh Jay Mathews; Lisa de Las Fuentes; Prashanth Podaralla; Anton Cabellon; Sijie Zheng; Andrew Bierhals; Karen Spence; Eduardo Slatopolsky; Victor G Davila-Roman; James A Delmez
Journal:  Am J Nephrol       Date:  2011-01-17       Impact factor: 3.754

5.  Fetuin-mineral complex reflects extraosseous calcification stress in CKD.

Authors:  Takayuki Hamano; Isao Matsui; Satoshi Mikami; Kodo Tomida; Naohiko Fujii; Enyu Imai; Hiromi Rakugi; Yoshitaka Isaka
Journal:  J Am Soc Nephrol       Date:  2010-10-14       Impact factor: 10.121

Review 6.  Inflammation and the osteogenic regulation of vascular calcification: a review and perspective.

Authors:  Jian-Su Shao; Su-Li Cheng; Justin Sadhu; Dwight A Towler
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

Review 7.  Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.

Authors:  Shinichiro Niizuma; Yoshitaka Iwanaga; Takaharu Yahata; Shunichi Miyazaki
Journal:  Front Cardiovasc Med       Date:  2017-03-06

8.  Association of fetuin-A levels and left ventricular diastolic dysfunction in patients on haemodialysis.

Authors:  Yangang Gan; Mingming Zhao; Jinhong Feng
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

9.  Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease.

Authors:  Magdalena Luczak; Joanna Suszynska-Zajczyk; Lukasz Marczak; Dorota Formanowicz; Elzbieta Pawliczak; Maria Wanic-Kossowska; Maciej Stobiecki
Journal:  Int J Mol Sci       Date:  2016-05-02       Impact factor: 5.923

10.  Fetuin-A and vascular calcification in Indian end-stage renal disease population.

Authors:  A Mann; V Makkar; S Mann; P Dhamija; P Soundarajan
Journal:  Indian J Nephrol       Date:  2016 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.